Mostrar el registro sencillo del documento

dc.rights.licenseAtribución-NoComercial 4.0 Internacional
dc.contributor.advisorZuñiga Pavia, Sergio Fabian
dc.contributor.authorRivillas Reyes, Juan Felipe
dc.date.accessioned2024-01-15T16:19:10Z
dc.date.available2024-01-15T16:19:10Z
dc.date.issued2024
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/85276
dc.description.abstractIntroducción: El cáncer de tiroides (CPT) y la Tiroiditis de Hashimoto (TH) son enfermedades comunes en la práctica clínica y en los últimos años se ha encontrado relación entre las características histopatológicas estas dos entidades. La premisa de que la inflamación crónica es un factor de riesgo para el desarrollo de malignidad está muy bien establecida para otro tipo de tumores (1), por el contrario, cuando se ha comparado a lo largo del tiempo el CPT y la TH se ha encontrado que podría llegar a tener el efecto contrario, por lo tanto, su asociación histopatológica es incierta hasta el momento. Es por esto que en este trabajo se pretende demostrar que los pacientes que cursan con TH tienen características histopatológicas que podrían favorecer el pronóstico de estos pacientes. Metodología: Se utilizó una cohorte histórica de pacientes sometidos a tiroidectomía total o parcial en el Hospital Universitario Nacional de Colombia (HUN) entre junio de 2017 y enero de 2021 con diagnósticos de CPT. Se revisaron los registros clínicos e histopatológicos de 1513 pacientes con patología tiroidea, de los cuales 959 pacientes cumplieron con los criterios de inclusión que se plantearon para este trabajo. Se realizó un análisis descriptivo para resumir las variables de la población total y por grupo, según la presencia o ausencia de tiroiditis de Hashimoto. Se emplearon pruebas estadísticas como el chi-cuadrado y la prueba exacta de Fisher para comparar las variables categóricas, y la prueba U de Mann-Whitney para las variables numéricas. El estudio se basó en un enfoque retrospectivo, observacional y transversal, y se utilizaron datos de la historia clínica electrónica del HUN. Además, se establecieron criterios de inclusión y exclusión, y se diseñó un formato electrónico para la captura y el análisis de la información de los pacientes incluidos en el estudio. Resultados: Se incluyeron un total de 919 pacientes sometidos a tiroidectomía por CPT, de los cuales 160 (16.6%) presentaban TH. El 84% de las tiroidectomías, fueron realizadas en mujeres. Se analizó la distribución de las variables según la presencia o ausencia de TH y se encontraron diferencias significativas en cuanto a los márgenes de resección positivos, la extensión extratiroidea y la invasión linfática, siendo más frecuentes en el grupo de CPT sin TH. Sin embargo, no se observaron diferencias estadísticamente significativas en el tamaño tumoral, la angioinvasión ni la invasión perineural. Asimismo, se detectó que los tumores tempranos (T1a y T1b) eran más comunes en el grupo con TH, mientras que los tumores más avanzados (T3a, T3b, T4a y T4b) se presentaron con mayor frecuencia en el grupo sin TH. Conclusión: Los pacientes que cursan con ambas enfermedades tienen una menor probabilidad de extensión extratiroidea, de invasión linfática, de márgenes de sección positivas y de ganglios linfáticos comprometidos. Encontramos relación histopatológica entre los pacientes que cursan con CPT y TH concomitantemente, lo que podría sugerir que estos pacientes tienen factores pronósticos favorables con respecto a aquellos que no cursan con TH. (Texto tomado de la fuente)
dc.description.abstractIntroduction: Thyroid cancer (TC) and Hashimoto's Thyroiditis (HT) are common diseases in clinical practice, and in recent years, a relationship has been found between the histopathological characteristics of these two entities. The premise that chronic inflammation is a risk factor for malignancy development is well established for other types of tumors (1). However, when TC and HT have been compared over time, it has been found that they may have the opposite effect. Therefore, their histopathological association remains uncertain at the moment. This is why this study aims to demonstrate that patients with HT exhibit histopathological characteristics that could favor their prognosis. Methodology: A historical cohort of patients who underwent total or partial thyroidectomy at the National University Hospital of Colombia (HUN) between June 2017 and January 2021 with a diagnosis of TC was used. Clinical and histopathological records of 1,513 patients with thyroid pathology were reviewed, of which 959 patients met the inclusion criteria set for this study. Descriptive analysis was conducted to summarize the variables for the total population and by group, based on the presence or absence of Hashimoto's thyroiditis. Statistical tests such as chi-square and Fisher's exact test were employed to compare categorical variables, and the Mann-Whitney U test was used for numerical variables. The study was based on a retrospective, observational, and cross-sectional approach, utilizing electronic medical records from HUN. In addition, inclusion and exclusion criteria were established, and an electronic format was designed for data capture and analysis of the patients included in the study Results: A total of 919 patients who underwent thyroidectomy for TC were included, of which 160 (16.6%) had HT. The diagnosis of TC and HT was made by the pathologist on the surgical specimen. 84% of thyroidectomies were performed on women. The distribution of variables was analyzed based on the presence or absence of HT, and significant differences were found in terms of positive resection margins and lymphatic invasion, which were more common in the TC and HT group. However, no statistically significant differences were observed in tumor size, extrathyroidal extension, angioinvasion, or perineural invasion. Furthermore, early tumors (T1a and T1b) were more common in the HT group, while more advanced tumors (T3a, T3b, T4a, and T4b) were more frequently seen in the group without HT. Conclusion: Patients with both diseases have a lower likelihood of extrathyroidal extension, lymphatic invasion, positive resection margins, and involved lymph nodes. These findings may have significant clinical implications and could help improve the management and follow-up of patients with TC and HT. However, more studies are needed to determine associations and prognosis for TC in patients concurrently experiencing HT. We found a histopathological relationship between patients with concurrent TC and HT, which suggests that these patients have favorable prognostic factors compared to those without HT.
dc.format.extentxiii, 35 páginas
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.titleAsociación de las características histopatológicas entre el cáncer papilar de tiroides y la tiroiditis de Hashimoto
dc.typeTrabajo de grado - Especialidad Médica
dc.type.driverinfo:eu-repo/semantics/bachelorThesis
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dc.publisher.programBogotá - Medicina - Especialidad en Cirugía General
dc.description.degreelevelEspecialidades Médicas
dc.description.degreenameCirujano general
dc.description.methodsTeniendo en cuenta la base de datos de una cohorte histórica tomada del servicio de cirugía de cabeza y cuello del Hospital Universitario Nacional de Colombia, se revisaron los registros clínicos e histopatológicos de todos los pacientes que se sometieron a tiroidectomía durante 43 meses desde junio de 2017 hasta enero de 2021. De los 1 513 pacientes operados por patología tiroidea en este periodo, 959 (63%) pacientes cumplieron con todos los criterios de inclusión establecidos más adelante. Todos los pacientes realizaron la consulta preoperatoria en la misma institución, para tomar la decisión de ser llevados a tiroidectomía. Se llevó a cabo un análisis descriptivo para resumir las variables de la población total y por grupo, según la presencia o ausencia de tiroiditis de Hashimoto. Posteriormente, se evaluaron las diferencias en la distribución de las variables entre los grupos, considerando el tipo y la distribución de cada variable. En el resumen de las variables categóricas se utilizó la frecuencia absoluta y el porcentaje, mientras que para las variables continuas se empleó la mediana y el rango intercuartílico debido a la no normalidad de la distribución según la prueba de Shapiro-Wilk. Se realizaron comparaciones entre los grupos mediante la prueba de chi-cuadrado y la prueba exacta de Fisher para las variables categóricas, y la prueba U de Mann-Whitney para las variables numéricas. Todos los análisis se desarrollaron mediante el programa Stata® 17 (StataCorp MP, College Station, TX).
dc.identifier.instnameUniversidad Nacional de Colombia
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourlhttps://repositorio.unal.edu.co/
dc.publisher.facultyFacultad de Medicina
dc.publisher.placeBogotá, Colombia
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.referencesKim KW, Park YJ, Kim EH, Park SY, Park DJ, Ahn SH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto’s thyroiditis. Head Neck. mayo de 2011;33(5):691–5.
dc.relation.referencesMuradas F, Bizarro M, Galleano C. Papillary thyroid carcinoma: Does the association with Hashimoto’s thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol. el 1 de mayo de 2015;81(3):283–7.
dc.relation.referencesHussein O, Abdelwahab K, Hamdy O, Awny S, Megahed NA, Hafez MT, et al. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area. J Egypt Natl Canc Inst. el 1 de diciembre de 2020;32(1).
dc.relation.referencesJeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: Clinical manifestation and prognostic outcome. J Korean Med Sci. agosto de 2012;27(8):883–9.
dc.relation.referencesEhlers M, Schott M. Hashimoto’s thyroiditis and papillary thyroid cancer: Are they immunologically linked? Vol. 25, Trends in Endocrinology and Metabolism. Elsevier Inc.; 2014. p. 656–64.
dc.relation.referencesJankovic B, Le KT, Hershman JM. Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation? Vol. 98, Journal of Clinical Endocrinology and Metabolism. 2013. p. 474–82.
dc.relation.referencesRepplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto’s Thyroiditis a Risk Factor for Papillary Thyroid Cancer? Journal of Surgical Research. noviembre de 2008;150(1):49–52
dc.relation.referencesde Alcântara-Jones DM, de Alcântara-Nunes TF, de Rocha BO, de Oliveira RD, Santana ACP, de Alcântara FT, et al. Is there any association between Hashimoto’s thyroiditis and thyroid cancer? A retrospective data analysis. Radiol Bras. el 23 de julio de 2015;48(3):148–53.
dc.relation.referencesLindsay S, Dailey M, Friedlander J, Yee G, Soley M. CHRONIC THYROIDITIS: A CLINICAL AND PATHO-LOGIC STUDY OF 354 PATIENTS*f. 1952.
dc.relation.referencesDailey M, Lindsay S, Skahen R. RELATION OF THYROID NEOPLASMS TO HASHIMOTO DISEASE OF THE THYROID GLAND. Archives of Surgery. el 1 de febrero de 1955;70(2):291.
dc.relation.referencesJackson D, Handelsman RS, Farrá JC, Lew JI. Increased Incidental Thyroid Cancer in Patients With Subclinical Chronic Lymphocytic Thyroiditis. Journal of Surgical Research. el 1 de enero de 2020;245:115–8.
dc.relation.referencesMolnár C, Molnár S, Bedekovics J, Mokánszki A, Győry F, Nagy E, et al. Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis. Pathology and Oncology Research. el 15 de julio de 2019;25(3):1191–7.
dc.relation.referencesOsorio C, Ballestas J, Correa J, Zambrano V, Rosales A, Camargo W, et al. Asociación entre tiroiditis linfocítica crónica y carcinoma papilar de tiroides: Revisión sistemática y metaanálisis de estudios en especímenes quirúrgicos Association between chronic lymphocityc thyroiditis and papillary thyroid carcinoma: Systematic review and meta-analysis of studies on surgical specimens. Revista Colombiana de Cirugia [Internet]. 2023;38:37–49. Disponible en: https://doi.org/10.30944/2011758.2228
dc.relation.referencesLun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, et al. Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngology - Head and Neck Surgery (United States). marzo de 2013;148(3):396–402
dc.relation.referencesZhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, et al. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease [Internet]. 2012. Disponible en: http://www.biomedcentral.com/1471-2407/12/610
dc.relation.referencesYe ZQ, Gu DN, Hu HY, Zhou YL, Hu XQ, Zhang XH. Hashimoto’s Thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer [Internet]. 2013. Disponible en: http://www.wjso.com/content/11/1/56
dc.relation.referencesNoureldine S, Tufano RP. Association of Hashimoto’s thyroiditis and thyroid cancer. Vol. 27, Current Opinion in Oncology. Lippincott Williams and Wilkins; 2015. p. 21–5.
dc.relation.referencesGrigerova M, Kasko M, Mojtova E, Takacsova E, Kralik R, Waczulikova I, et al. Infl uence of autoimmune thyroiditis on the prognosis of papillary thyroid carcinoma. Bratislava Medical Journal. 2022;123(12):885–90
dc.relation.referencesMa B, Chen X, Zhao Z, Yin X, Ji Q, Zhou Y, et al. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients. BMC Endocr Disord. el 1 de diciembre de 2022;22(1).
dc.relation.referencesLee I, Kim HK, Soh EY, Lee J. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer. World J Surg. el 1 de mayo de 2020;44(5):1506–13
dc.relation.referencesSubhi O, Schulten HJ, Bagatian N, Al-Dayini R, Karim S, Bakhashab S, et al. Genetic relationship between Hashimoto’s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto’s thyroiditis. PLoS One. el 1 de junio de 2020;15(6 June).
dc.relation.referencesde Paiva CR, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto’s thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. el 10 de abril de 2017;7(APR).
dc.relation.referencesConsorti F, Loponte M, Milazzo F, Potasso L, Antonaci A. Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto’s Thyroiditis. European Surgical Research. diciembre de 2010;45(3–4):333–7
dc.relation.referencesAhn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol (Madr). noviembre de 2011;50(8):1228–34
dc.relation.referencesChen S, Niu C, Peng Q, Tang K. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto’s Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis. Front Endocrinol (Lausanne). el 15 de marzo de 2021;12
dc.relation.referencesCheng V, Brainard J, Nasr C. Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimoto’s thyroiditis. Thyroid. el 1 de junio de 2012;22(6):647–50.
dc.relation.referencesHaugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. el 1 de enero de 2016;26(1):1–133.
dc.relation.referencesSchneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Vol. 1, Nature clinical practice. Endocrinology & metabolism. 2005. p. 82–91.
dc.relation.referencesPal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, et al. Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based Study. 2001.
dc.relation.referencesMedici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease. PLoS Genet. febrero de 2014;10(2).
dc.relation.referencesMclachlan SM, Feldt-Rasmussen U, Young ET, Middleton SL, Blichert-Toft M, Rees B, et al. IgG SUBCLASS DISTRIBUTION OF THYROID AUTOANTIBODIES: A “FINGERPRINT” OF AN INDIVIDUAL’S RESPONSE TO THYROGLOBULIN AND THYROID MICROSOMAL ANTIGEN. Vol. 26, Clinical Endocrinology. 1987.
dc.relation.referencesKraiem Z, Lahat N, Glaser B, Baron E, N D M Sheinfeld SA. THYROTROPHIN RECEPTOR BLOCKING ANTIBODIES: INCIDENCE, CHARACTERIZATION AND IN-VITRO SYNTHESIS. Vol. 27, Clinical Endocrinology. 1987.
dc.relation.referencesTao L, Xi-lin H, Xiang-dong M. Surgical Treatment of Hashimoto’s with Thyroid Microcarcinoma. Cell Biochem Biophys. el 30 de noviembre de 2015;72(1):123–6.
dc.relation.referencesGraceffa G, Patrone R, Vieni S, Campanella S, Calamia S, Laise I, et al. Association between Hashimoto’s thyroiditis and papillary thyroid carcinoma: A retrospective analysis of 305 patients. BMC Endocr Disord. el 29 de mayo de 2019;19
dc.relation.referencesLee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically-2 proven Hashimoto’s thyroiditis: a meta-analysis Corresponding author: Young-Sik. 2012.
dc.relation.referencesEvren B, Yılmaz S, Karadağ N, Sertkaya AÇ, Topaloğlu Ö, Kılınç F. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter. Sci Rep. el 1 de diciembre de 2021;11(1).
dc.relation.referencesGiagourta I, Evangelopoulou C, Papaioannou G, Kassi G, Zapanti E, Prokopiou M, et al. Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head Neck. 2014;36(4):531–5.
dc.relation.referencesKonturek A, Barczyński M, Wierzchowski W, Stopa M, Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg. marzo de 2013;398(3):389–94.
dc.relation.referencesFish SA. Clinical THYROIDOLOGY ® 333 l Hashimoto’s Thyroiditis Is a Risk Factor for Thyroid Cancer [Internet]. Vol. 31. 2019. Disponible en: www.liebertpub.com
dc.relation.referencesNeyd Anil C, Goksel S, Gursoy A. Hashimoto’s Thyroiditis Is Not Associated with Increased Risk of Thyroid Cancer in Patients with Thyroid Nodules: A Single-Center Prospective Study.
dc.relation.referencesXu J, Ding K, Mu L, Huang J, Ye F, Peng Y, et al. Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma. Front Endocrinol (Lausanne). el 24 de febrero de 2022;13.
dc.relation.referencesKebebew E, Treseler PA, Ituarte PHG, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. mayo de 2001;25(5):632–7
dc.relation.referencesHuang BY, Hseuh C, Chao TC, Lin KJ, Lin J Der. Well-differentiated thyroid carcinoma with concomitant Hashimoto’s thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol. septiembre de 2011;22(3):144–9.
dc.relation.referencesKurukahvecioglu O, Taneri F, Yüksel O, Aydin A, Tezel E, Onuk E. Total Thyroidectomy for the Treatment of Hashimoto’s Thyroiditis Coexisting With Papillary Thyroid Carcinoma
dc.relation.referencesBatool S, Das B, Arif M, Islam N. FREQUENCY OF HASHIMOTO THYROIDITIS IN PAPILLARY THYROID CANCER PATIENTS AND ITS IMPACT ON THEIR OUTCOME [Internet]. Vol. 34, J Ayub Med Coll Abbottabad. 2022. Disponible en: http://www.jamc.ayubmed.edu.pk
dc.relation.referencesTamimi DM. The Association Between Chronic Lymphocytic Thyroiditis and Thyroid Tumors. Vol. 10, International Journal of Surgical Pathology. 2002.
dc.relation.referencesKim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, et al. Chronic lymphocytic thyroiditis and braf v600e in papillary thyroid carcinoma. Endocr Relat Cancer. el 1 de enero de 2016;23(1):27–34.
dc.relation.referencesKwak HY, Chae BJ, Eom YH, Hong YR, Seo JB, Lee SH, et al. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol. el 15 de octubre de 2015;20(3):463–73.
dc.relation.referencesSantoro’ M, Sabino5 N, Ishizaka3 Y, Ushijima3 T, Carlomagnol F, Cerratol A, et al. Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Vol. 68, Br. J. Cancer. 1993.
dc.relation.referencesLau J, Lee J, Mahipal M, Yang SP, Tan WB, Yuan NK, et al. Hashimoto’s thyroiditis on outcomes in papillary thyroid cancer revisited: experience from South East Asia. Ann R Coll Surg Engl. el 1 de junio de 2022;104(6):465–71.
dc.relation.referencesKonturek A, Barczyński M, Nowak W, Wierzchowski W. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto’s thyroiditis. Langenbecks Arch Surg. 2014;399(2):229–36.
dc.relation.referencesAsanuma K, Sugenoya A, Kasuga Y, Itoh N, Kobayashi S, Amano J. The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis.
dc.relation.referencesLiang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, et al. Analisi clinica dell’associazione fra tiroidite di Hashimoto e carcinoma papillare della tiroide in 1392 pazienti. Acta Otorhinolaryngologica Italica. el 1 de octubre de 2017;37(5):393–400.
dc.relation.referencesCampos LAAF, Picado SM, Guimarães AV, Ribeiro DA, Dedivitis RA. Thyroid papillary carcinoma associated to hashimoto’s thyroiditis. Braz J Otorhinolaryngol. 2012;78(6):77–80.
dc.relation.referencesZhu F, Shen Y Bin, Li FQ, Fang Y, Hu L, Wu YJ. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma. Medicine (United States). el 1 de febrero de 2016;95(6).
dc.relation.referencesLee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically-2 proven Hashimoto’s thyroiditis: a meta-analysis Corresponding author: Young-Sik. 2012.
dc.relation.referencesNasiri S, Yazd SMM, Gholami M, Shahriarirad S, Sharghi S, Shahriarirad R. The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study. BMC Endocr Disord. el 1 de diciembre de 2023;23(1).
dc.relation.referencesHanege FM, Tuysuz O, Celik S, Sakallıoglu O, Solmaz OA. Hashimoto’s thyroiditis in papillary thyroid carcinoma: A 22-year study. Acta Otorhinolaryngologica Italica. 2021;41(2):142–5.
dc.relation.referencesTang Q, Pan W, Peng L. Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis. PLoS One. el 1 de junio de 2022;17(6 June).
dc.relation.referencesLarson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, et al. Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway. J Am Coll Surg. mayo de 2007;204(5):764–73.
dc.relation.referencesKim SJ, Lee SE, Kim Y Il, Nam-Goong IS, Jung HW, Kim ES. Papillary thyroid cancer with Hashimoto’s thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression. Clin Exp Med. el 1 de julio de 2022;
dc.relation.referencesSchäffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, et al. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Vol. 28, European Journal of Clinical Investigation. 1998.
dc.relation.referencesYoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. European Archives of Oto-Rhino-Laryngology. marzo de 2012;269(3):1013–7.
dc.relation.referencesZhang Y, Ma X peng, Deng F sheng, Liu Z rong, Wei H qing, Wang X hong, et al. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer. World J Surg Oncol. el 1 de septiembre de 2014;12(1).
dc.relation.referencesSelek A, Cetinarslan B, Tarkun I, Canturk Z, Ustuner B, Akyay Z. Thyroid autoimmunity: is really associated with papillary thyroid carcinoma? European Archives of Oto-Rhino-Laryngology. el 1 de marzo de 2017;274(3):1677–81.
dc.relation.referencesSook Kim E, Jun Lim D, Hyun Baek K, Min Lee J, Kyoung Kim M, Sang Kwon H, et al. Thyroglobulin Antibody Is Associated with Increased Cancer Risk in Thyroid Nodules [Internet]. Disponible en: www.liebertpub.com
dc.relation.referencesMac Dermott MM, Gauna A, de Yampey JEW. Impacto del compromiso ganglionar en el pronóstico y la evolución del carcinoma papilar de tiroides. Rev Argent Endocrinol Metab. abril de 2017;54(2):51–63.
dc.relation.referencesDonangelo I, Walts AE, Bresee C, Braunstein GD. Lymphocytic thypoiditis is associated with increase number of bening cervical noded and fewer central neck compartment metastatic lymph nodes in patients with differentiated thyroid cancer. Endocrine Practice. 2016;22(10):1192–5.
dc.relation.referencesYoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. European Archives of Oto-Rhino-Laryngology. marzo de 2012;269(3):1013–7.
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.decsCáncer Papilar Tiroideo
dc.subject.lembThyroid Cancer, Papillary
dc.subject.proposalCáncer de Tiroides Papilar
dc.subject.proposalNeoplasias de Tiroides
dc.subject.proposalExtensión Extranodal
dc.subject.proposalTiroiditis Autoinmune
dc.subject.proposalEnfermedad de Hashimoto
dc.subject.proposalHashimoto Disease
dc.subject.proposalThyroid Cancer
dc.subject.proposalThyroid Neoplasms
dc.subject.proposalExtranodal Extension
dc.subject.proposalThyroiditis, Autoimmune
dc.title.translatedAssociation of histopathological characteristics between papillary thyroid cancer and Hashimoto's thyroiditis
dc.type.coarhttp://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.contentText
dc.type.redcolhttp://purl.org/redcol/resource_type/TP
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2
dcterms.audience.professionaldevelopmentPúblico general
dc.contributor.orcidJuan Felipe Rivillas Reyes [0000-0002-2181-7621]


Archivos en el documento

Thumbnail

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento

Atribución-NoComercial 4.0 InternacionalEsta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial 4.0.Este documento ha sido depositado por parte de el(los) autor(es) bajo la siguiente constancia de depósito